Literature DB >> 20729317

Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.

Shaw R Gargis1, Harry E Heath, Paul A LeBlanc, Linda Dekker, Robin S Simmonds, Gary L Sloan.   

Abstract

Resistance to lysostaphin, a staphylolytic glycylglycine endopeptidase, is due to a FemABX-like immunity protein that inserts serines in place of some glycines in peptidoglycan cross bridges. These modifications inhibit both binding of the recombinant cell wall targeting domain and catalysis by the recombinant catalytic domain of lysostaphin.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20729317      PMCID： PMC2953023          DOI： 10.1128/AEM.01066-10

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  18 in total

1.  The molecular organization of the lysostaphin gene and its sequences repeated in tandem.

Authors:  P Heinrich; R Rosenstein; M Böhmer; P Sonner; F Götz
Journal:  Mol Gen Genet       Date:  1987-10

2.  Transformation of Escherichia coli with large DNA molecules by electroporation.

Authors:  Y Sheng; V Mancino; B Birren
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

3.  Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus.

Authors:  H E Heath; L S Heath; J D Nitterauer; K E Rose; G L Sloan
Journal:  Biochem Biophys Res Commun       Date:  1989-05-15       Impact factor: 3.575

4.  Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.

Authors:  J M Robinson; J K Hardman; G L Sloan
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus.

Authors:  T Baba; O Schneewind
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

7.  Lysostaphin endopeptidase-catalysed transpeptidation reactions of the imino-transfer type.

Authors:  G L Sloan; E C Smith; J H Lancaster
Journal:  Biochem J       Date:  1977-10-01       Impact factor: 3.857

8.  Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans.

Authors:  P A Recsei; A D Gruss; R P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Functional characterization of domains found within a lytic enzyme produced by Streptococcus equi subsp. zooepidemicus.

Authors:  A C-Y Lai; S Tran; R S Simmonds
Journal:  FEMS Microbiol Lett       Date:  2002-09-24       Impact factor: 2.742

10.  The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.

Authors:  H P DeHart; H E Heath; L S Heath; P A LeBlanc; G L Sloan
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792
View more
  7 in total

1.  In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.

Authors:  Evgeny A Idelevich; Christof von Eiff; Alexander W Friedrich; Domenico Iannelli; Guoqing Xia; Georg Peters; Andreas Peschel; Ingrid Wanninger; Karsten Becker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

2.  Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.

Authors:  Daniel C Osipovitch; Sophie Therrien; Karl E Griswold
Journal:  Appl Microbiol Biotechnol       Date:  2015-02-18       Impact factor: 4.813

3.  Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.

Authors:  Daniel C Osipovitch; Karl E Griswold
Journal:  FEMS Microbiol Lett       Date:  2014-12-08       Impact factor: 2.742

4.  Influence of NaCl and pH on lysostaphin catalytic activity, cell binding, and bacteriolytic activity.

Authors:  Svetlana Konstantinova; Alexander Grishin; Alexander Lyashchuk; Irina Vasina; Anna Karyagina; Vladimir Lunin
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-16       Impact factor: 5.560

5.  Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model.

Authors:  Ceylan D Windolf; Tim Lögters; Martin Scholz; Joachim Windolf; Sascha Flohé
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

6.  Structural bases of peptidoglycan recognition by lysostaphin SH3b domain.

Authors:  Paweł Mitkowski; Elżbieta Jagielska; Elżbieta Nowak; Janusz M Bujnicki; Filip Stefaniak; Dorota Niedziałek; Matthias Bochtler; Izabela Sabała
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

7.  Structural Characterization of EnpA D,L-Endopeptidase from Enterococcus faecalis Prophage Provides Insights into Substrate Specificity of M23 Peptidases.

Authors:  Piotr Henryk Małecki; Paweł Mitkowski; Elżbieta Jagielska; Karolina Trochimiak; Stéphane Mesnage; Izabela Sabała
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.